INTENSIFIED METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN (I-MVAC) WITH OR WITHOUT PANITUMUMAB AS FIRST-LINE TREATMENT OF ADVANCED UROTHELIAL CARCINOMA IN PATIENTS WITHOUT H-Ras NOR K-Ras MUTATIONS. RANDOMISED PHASE II STUDY